-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

622.O1.6 622. Lymphomas: Translational–Non-Genetic: Tumor Microenvironment in Lymphoid Malignancies: Composition, Biology, and Prognostic Significance

Symposia: Lymphomas: Translational–Non-Genetic Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Hodgkin lymphoma, Viral, Fundamental Science, adult, Translational Research, Lymphomas, non-Hodgkin lymphoma, B Cell lymphoma, immune mechanism, Diseases, Immune Disorders, immunodeficiency, indolent lymphoma, immunology, aggressive lymphoma, Therapies, Infectious Diseases, Lymphoid Malignancies, computational biology, young adult , Biological Processes, Technology and Procedures, Study Population, multi-systemic interactions, Human, pathogenesis, imaging, machine learning, omics technologies, Pathology
Saturday, December 10, 2022: 9:30 AM-11:00 AM
New Orleans Theater C (Ernest N. Morial Convention Center)
Moderators:
Andrew M. Intlekofer, MD, DPhil, Memorial Sloan Kettering Cancer Center and Leandro Cerchietti, MD, Weill Cornell Medical College
Disclosures:
No relevant conflicts of interest to declare.
9:30 AM

Dylan McNally1*, Andrew Lytle, MD, PhD2*, Hiranmayi Ravichandran3*, Wayne Tam, MD, PhD4, Christian Steidl5*, David W. Scott, PhD, MD, FRACP, FRCPA6, Ari Melnick, MD7 and Olivier Elemento, PhD8*

1Physiology, Biophysics, and Systems Biology graduate program, Weill Cornell Medicine Graduate School of Medical Sciences, New York, NY
2Centre for Lymphoid Cancer, Department of Pathology, BC Cancer, Vancouver, BC, Canada
3Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY
4Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
5Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
6British Columbia Cancer Agency, Vancouver, BC, Canada
7Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY
8Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY

9:45 AM

Troy Noordenbos1*, Fleur A De Groot2*, Ruben A.L. De Groen, MSc2*, Lorraine M. De Haan1*, Ricki T. Krog1,3*, Aniko Sijs-Szabo2*, Marieke Griffioen2*, Rosa de Groot2*, Mirjam H.M. Heemskerk2, Marieke E. Ijsselsteijn1*, Valeska Terpstra4*, Marcel Nijland, MD, PhD5*, Pim Mutseaers, MD6*, Martine E.D. Chamuleau, MD, PhD7, Marie Jose Kersten, MD, PhD8,9, Arjan Diepstra, M.D., Ph.D.10, Judith Bovée1*, Patty M. Jansen1*, Noel F.C.C. De Miranda1* and Joost S.P. Vermaat, MD, PhD2

1Department of Pathology, Leiden University Medical Center, Leiden, Netherlands
2Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
3Department of Surgery, Leiden University Medical Center, Leiden, Netherlands
4Pathology, Haaglanden MC, Den Haag, Netherlands
5Department of Hematology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands
6Department of Hematology, Erasmus MC Cancer Center, Rotterdam, Netherlands
7Amsterdam UMC, Vrije Universiteit Amsterdam, department of Hematology, Cancer Center Amsterdam, Amsterdam, Netherlands
8Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, Netherlands
9Lymphoma and Myeloma Center Amsterdam-LYMMCARE, Amsterdam, Netherlands
10Department of Pathology and Medical Biology, University of Groningen, Groningen, Netherlands

10:00 AM

David J. Reiss1*, C. Chris Huang, PhD2*, Yumi Nakayama, PhD2*, Matthew E. Stokes3*, Andrew P. Weng, MD4 and Anita K. Gandhi, PhD2

1Bristol Myers Squibb, Seattle, WA
2Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ
3Bristol Myers Squibb, Summit, NJ
4Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada

10:15 AM

Patrizia Mondello, MD, PhD, MSc1, Kerstin Wenzl, PhD1, Zhi-Zhang Yang, MD1, Changjin Hong2*, Jordan E. Krull1, Xinyi Tang, MD, PhD1*, Vaishali Bhardwaj, PhD1, Joseph P. Novak1*, Hyojin Kim, PhD1*, Prithviraj Mukherjee, Ph.D1*, Rebecca L. King3*, Tae Hyun Hwang2*, Mark J Shlomchik4*, Anne J. Novak, PhD1 and Stephen M. Ansell, MD, PhD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Artificial Intelligence and Informatics, Mayo Clinic, Jacksonville, FL
3Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, Rochester
4Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA

10:30 AM

Tomohiro Aoki, MD, PhD1,2, Aixiang Jiang, MSc1,2*, Alexander Xu, PhD3, Alicia Gamboa3*, Yifan Yin1*, Katy Milne4*, Celia Strong4*, Talia Goodyear4*, Shaocheng Wu5*, Lauren C. Chong1*, Katsuyoshi Takata, MD, PhD1*, Elizabeth Chavez, BSc, Cg RT1*, Tomoko Miyata-Takata, MD1*, Anthony R. Colombo, MS3*, Monirath Hav3*, Adele Telenius1*, Susana Ben-Neriah, MSc1*, Andrew P. Weng, MD6, Kerry J. Savage, MD, MSc, FRCPC7, David W. Scott, PhD, MD, FRACP, FRCPA1, Andrew Roth5*, Pedro Farinha, MD, PhD2,8*, Brad H Nelson4*, Akil Merchant, MD3 and Christian Steidl1,2*

1Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
3Cedars-Sinai Medical Center, Los Angeles, CA
4Deeley Research Centre, BC Cancer, Victoria, BC, Canada
5BC Cancer, Department of Molecular Oncology, Vancouver, BC, Canada
6Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada
7BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
8Centre for Lymphoid Cancer and Department of Pathology, BC Cancer, Vancouver, BC, Canada

10:45 AM

Joseph Schroers-Martin, MD1, Andrea Garofalo2*, Joanne Soo, MD3, Jan Boegeholz, MD4, Stefan K. Alig, MD5, Brian Sworder, MD, PhD6, Chih Long Liu, PhD7*, Helen Luikart, RN, MSN8*, Gerardo Gamino8*, DP Morales8*, Kathrin Freystätter9*, James Hamilton III4*, David M. Kurtz, MD, PhD3,10, Seth Hollander, MD11*, David Rosenthal, MD11*, Gundeep Dhillon, MD12*, Jayant Raikhelkar, MD13*, Stijn Verleden, PhD14*, Marcel Nijland, MD, PhD15*, Sean Agbor-Enoh, MD, PhD16*, Martin Andreas, MBA, PhD, MEBCTS9*, Abdallah Kfoury, MD17*, Heather Ross, MD18*, Lorenzo Zaffiri, MD, PhD19*, Yasodha Natkunam, MD, PhD20, Maximilian Diehn, MD, PhD21*, Kiran Khush, MD8* and Ash A. Alizadeh, MD, PhD22

1Stanford University, Stanford, CA
2Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA
3Department of Medicine, Divisions of Hematology & Oncology, Stanford University, Stanford, CA
4Divisions of Hematology & Oncology, Stanford University, Stanford, CA
5Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
6Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
7Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
8Division of Cardiovascular Medicine, Stanford University, Stanford, CA
9Medical University of Vienna, Vienna, Austria
10Stanford University, Palo Alto, CA
11Department of Pediatrics, Division of Pediatric Cardiology, Stanford University, Stanford, CA
12Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University, Stanford, CA
13Columbia University Irving Medical Center, Cardio-Oncology, New York, NY
14University of Antwerp, Antwerp, Belgium
15Department of Hematology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands
16Laboratory of Applied Precision Omics, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD
17Intermountain Healthcare, Salt Lake City, UT
18Toronto General Hospital, Toronto, ON, Canada
19Cedars Sinai Medical Center, Beverly Hills, CA
20Stanford University School of Medicine, Stanford, CA
21Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
22Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, San Mateo, CA

*signifies non-member of ASH